SPRC
2023-12-15 to 2024-03-16
Price Derived Levels
4.40 4.91 5.90 6.78 14.22
Volume Derived Levels
3.35 4.63 5.61 6.41
PoC
5.54 - 5.72
Gaps
No Gaps
Chart Definitions
Price Derived S/R: These lines are derived from pivots points in the raw price data and are massaged to minimize the error between the pivot points and the s/r lines.
Volume Derived S/R: These lines are derived by using intra-day volume to identify points of control. These daily areas of increased activity are then used to identify critical levels over the requested timeframe.
Point of Control (POC): This range represents where the majority of intra-day volume occurred over the requested timeframe.
Gap: These ranges show areas of gaps in the price action which often act as magnets. Gaps like to be closed.
Company Overview
Scisparc Ltd
Sector: Healthcare
Web URL: https://scisparc.com
IPO Date: 2021-08-30
Exchange: NASDAQ
Industry: Biotechnology
Country Name: USA
Full Time Employees: 3
Description: SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and epilepsy and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation, as well as a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. The company was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Fundamentals
Book Value: 14.485
Short: -
Insider %: 0.07
Institutions %: 8.85
52 Week High: 23.66
52 Week Low: 2.311
Eps: -
ROA: -0.3311
Piotroski F-Score: 0/9
Squeeze: -
Financials
Fiscal Date Ending: 2023-06-30
Net Borrowings: -13.00k
Cash: 2.08M
Cash Per Share: 1.90
Cash Flow From Financing: 2.81M
Net Income: -2.88M
Change In Cash: -1.51M
Stock Sale And Purchase: NA
Change In Net Income: 4.50k
Change In Cash And Cash Equivalents: -1.51M
Float
Internal: 258.69k
Finviz: -
Yahoo: -
TDAmeritrade: -
Targets
Average: -
Max: -
Min: -
Forecasted Change: -
Analyst Count: -
All trading strategies are used at your own risk. Data produced by the 'FrogOracle' is not intended to be a buy or sell signal.